{
    "Overall_score": {
        "Correlation": 7,
        "Sentiment": 6,
        "Importance": 7,
        "Impact": 6,
        "Duration": 5,
        "Virality": 4,
        "Source_Score": 5,
        "Specificity": 7,
        "Sector_Spread": 8,
        "Tech_Mentions": 3
    },
    "Each_item": [
        {
            "News_content": "Are you considering selling $CFX $ABBV $TWC $CBM",
            "Correlation": 5,
            "Sentiment": 4,
            "Importance": 4,
            "Impact": 3,
            "Duration": 2,
            "Virality": 3,
            "Source_Score": 4,
            "Specificity": 5,
            "Sector_Spread": 7,
            "Tech_Mentions": 1
        },
        {
            "News_content": "RT @jnd24303: A lot of expectations for $GILD hepC market share. Zero expectations for $ABBV hepC market share. Invest accordingly.",
            "Correlation": 8,
            "Sentiment": 6,
            "Importance": 7,
            "Impact": 6,
            "Duration": 5,
            "Virality": 5,
            "Source_Score": 6,
            "Specificity": 8,
            "Sector_Spread": 6,
            "Tech_Mentions": 2
        },
        {
            "News_content": "$ABBV Gilead climbs after hep C drug sales top $2B in Q1",
            "Correlation": 9,
            "Sentiment": 8,
            "Importance": 9,
            "Impact": 8,
            "Duration": 7,
            "Virality": 6,
            "Source_Score": 7,
            "Specificity": 9,
            "Sector_Spread": 8,
            "Tech_Mentions": 4
        }
    ]
}